Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium

International Journal of Cancer

Volumn 128, Issue 4, 2011, Pages 936-943

  Lurie, Galina ^a   Wilkens, Lynne R ^a   Thompson, Pamela J ^a   Carney, Michael E ^b   Palmieri, Rachel T ^c   Pharoah, Paul D P ^d   Song, Honglin ^d   Hogdall, Estrid ^e   Kjaer, Susanne Kruger ^e,f   Dicioccio, Richard A ^g   McGuire, Valerie ^h   Whittemore, Alice S ^h   Gayther, Simon A ⁱ   Gentry Maharaj, Aleksandra ⁱ   Menon, Usha ⁱ   Ramus, Susan J ⁱ   Goodman, Marc T ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

case control study; invasive ovarian carcinoma; pooled analysis; single nucleotide polymorphism; vitamin D receptor gene (VDR)

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEREDITY; HETEROZYGOSITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK FACTORS; YOUNG ADULT;

EID: 78650587328     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25403     Document Type: Article

References (35)

1. Holick MF,. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006; 92: 49-59.
2. Lefkowitz ES, Garland CF,. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994; 23: 1133-6.
3. Garland CF, Mohr SB, Gorham ED, Grant WB, Garland FC,. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 2006; 31: 512-4.
4. Lipkin M, Newmark HL,. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr 1999; 18 (Suppl.): 392S-7S.
5. Cui Y, Rohan TE,. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2006; 15: 1427-37.
6. Flood A, Peters U, Chatterjee N, Lacey JV, Jr, Schairer C, Schatzkin A,. Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Cancer Epidemiol Biomarkers Prev 2005; 14: 126-32.
7. Park SY, Murphy SP, Wilkens LR, Nomura AM, Henderson BE, Kolonel LN,. Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. Am J Epidemiol 2007; 165: 784-93.
8. Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Nomura AM, Kolonel LN,. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol 2004; 159: 750-8.
9. Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, Escudero-De Los Rios P, Hernandez-Avila M,. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 2002; 63: 151-7.
10. Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK, Malone JM, Deppe G,. Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anticancer Drugs 1993; 4: 201-8.
11. Jiang F, Bao J, Li P, Nicosia SV, Bai W,. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 2004; 279: 53213-21.
12. Saunders DE, Christensen C, Lawrence WD, Malviya VK, Malone JM, Williams JR, Deppe G,. Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol 1992; 44: 131-6.
13. Ahonen MH, Zhuang YH, Aine R, Ylikomi T, Tuohimaa P,. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 2000; 86: 40-6.
14. Villena-Heinsen C, Meyberg R, Axt-Fliedner R, Reitnauer K, Reichrath J, Friedrich M,. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3- receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res 2002; 22: 2261-7.
15. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP,. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143-56.
16. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D,. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 1998; 13: 1691-9.
17. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR,. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000; 14: 401-20.
18. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas DC, Haussler MR,. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001; 177: 145-59.
19. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT,. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 2566-71.
20. Berchuck A, Schildkraut JM, Pearce CL, Chenevix-Trench G, Pharoah PD,. Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international Ovarian Cancer Association Consortium. Adv Exp Med Biol 2008; 622: 53-67.
21. Soegaard M, Jensen A, Hogdall E, Christensen L, Hogdall C, Blaakaer J, Kjaer SK,. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1160-6.
22. Song H, Ramus SJ, Quaye L, Dicioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 2006; 27: 2235-42. (Pubitemid 44644812)
23. McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, West DW, Whittemore AS,. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol 2004; 160: 613-8.
24. Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 2008; 123: 380-8.
25. Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, Thompson PJ, Wilkens LR, Tung KH, Ness RB, Goodman MT,. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and. IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004; 95: 672-9.
26. Sutton AJ, Abrams KR, Jones D, Sheldon DR, Song F,. Methods for meta-analysis in medical research. New York: Wiley, 2002.
27. Tworoger SS, Gate MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE,. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 2009; 69: 1885-91.
28. Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, et al. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 2008; 260: 209-15.
29. Deeb KK, Trump DL, Johnson CS,. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684-700.
30. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhager JC, Pols HA, van Leeuwen JP,. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 2000; 52: 211-6.
31. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E,. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997; 12: 915-21.
32. Lanske B, Razzaque MS,. Vitamin D and aging: old concepts and new insights. J Nutr Biochem 2007; 18: 771-7.
33. Gilad LA, Schwartz B,. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor. J Mol Endocrinol 2007; 38: 603-18.
34. Tang S, Han H, Bajic V,. ERGDB: estrogen responsive genes database. Nucleic Acids Res 2004; 32: D533-6.
35. Protiva P, cross HS, Hopkins ME, Kallay E, Bises G, dreihaupt E, Augenlicht L, Lipkin M, Lesser M, Livote E, Holt PK,. Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prevention Res 2009; 2: 43-51.